Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy

BACKGROUND: Accurate risk stratification can help guide appropriate treatment decisions in men with localized prostate cancer. Here, we evaluated the independent ability of the molecular cell cycle progression (CCP) score and the combined cell-cycle clinical risk (CCR) score to predict 10-year risk...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate Cancer Prostatic Dis
Main Authors: Canter, Daniel J., Freedland, Stephen, Rajamani, Saradha, Latsis, Maria, Variano, Margaret, Halat, Shams, Tward, Jonathan, Cohen, Todd, Stone, Steven, Schlomm, Thorsten, Bishoff, Jay, Bardot, Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7027968/
https://ncbi.nlm.nih.gov/pubmed/31243337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41391-019-0159-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados